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1. Introduction
Magnetic nanoparticles (MNPs) continue to be the sub-
ject of extensive research owing to their potential to offer 
transformative improvements in a wide range of applica-
tions including magnetic separation,[1] ultrahigh density 
data storage,[2] catalysis,[3] and increasingly the important 
field of nanomedicine. Magnetite nanoparticles (Fe3O4) 
in particular are used in numerous advanced diagnostic 
and therapeutic applications including magnetic reso-
nance imaging (MRI) contrast agents and targeted mag-
netic hyperthermia treatment of tumours.[4–8] Magnetite 
is stable, non-toxic, and has the highest magnetic satura-
tion of all the iron oxides with Fe2+ and Fe3+ centres in a 
1:2 ratio (Fe2+Fe3+2O4).[9] Spherical magnetite nanoparti-
cles are superparamagnetic below ≈30 nm and exhibit 
multi-domain magnetic characteristics above ≈90 nm 
at ambient temperature. Between this range the MNPs 
are single-domain ferrimagnets offering the highest 
magnetic saturation per volume, making them optimal 
for many medical and nanotechnological applications. 
Magnetite can be formed simply by raising the pH of a 
mixed valence iron solution under an inert atmosphere 
to precipitate the oxide. However, this often leads to a 
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heterogeneous population of particle size, shape, and 
contamination with other iron oxides. More uniform pop-
ulations of pure magnetite nanoparticles can be produced, 
but only via multistep processes involving increased tem-
perature, pressure, and/or toxic reagents.[10] It remains a 
significant challenge to produce aqueous suspensions of 
monodisperse, single-domain magnetite nanoparticles 
under ambient conditions.
Magnetotactic bacteria (MTB) are heterogeneously 
diverse aquatic microbes that possess the ability to 
align and swim along magnetic field lines. Under micro-
aerobic conditions they take up iron ions from the 
environment and produce intracellular nanoparticles 
of magnetite. The nanoparticles, which are “single-
domain” magnets and underlay the cells’ magnetotaxis, 
form within lipid vesicles termed “magnetosomes.”[11,12] 
The MNP size ranges from 40 to 100 nm in diameter 
depending on the species and since their discovery MTB 
have provided the inspiration to develop biominerali-
zation routes to obtain homogeneous single-domain 
MNPs.[13] To form the MNP, the internal liposome is 
first invaginated from the bacteria’s cytoplasmic mem-
brane and in doing so recruits a series of biominerali-
zation proteins[14] that orchestrate the process of MNP 
crystallization by: (i) importing iron ions into the lipo-
some, (ii) maintaining the correct chemical environ-
ment within the liposome for magnetite to form (i.e., 
correct redox potential, high pH), (iii) nucleating the 
iron ions to initiate crystallization, and (iv) controlling 
crystallization precisely to produce an MNP of a fixed 
size and morphology.[15–17]
The merits of using magnetosomes for biomedical 
applications are well established. The phospholipid 
bilayer surrounding the magnetosome is readily func-
tionalizable with various biological moieties for their use 
in biomedical applications and extensive research has 
been carried out to exploit this.[18] Native bacterial pro-
teins have been thoroughly investigated as anchor sites 
for the expression of foreign proteins (e.g., Protein A, lucif-
erase, and acetate kinase) on the surface of the magneto-
some.[19] In magnetic hyperthermia, magnetosomes[20] 
and magnetically modified magnetosomes[21] have been 
shown to be superior to equivalent synthetically pro-
duced MNPs.[22] However, magnetosomes have several 
disadvantages: the extent to which magnetosomes can 
be modified within the bacteria is very restricted due to 
cell toxicity, furthermore the MTB are slow-growing and 
difficult to cultivate. The large-scale fermenter growth of 
several magnetic bacteria has also been performed and 
this has seen improved yields leading to the hope of real-
izing technological exploitation. However, biomineraliza-
tion in magnetic bacteria, even in an improved fermenter 
system, is a highly inefficient method of producing MNPs, 
with low yields presenting a barrier to the successful 
commercialization of the magnetosomes. The utiliza-
tion of magnetosomes for more varied MNP applications 
has also been limited due to the fact that the magnetic 
properties of magnetosomes cannot be varied due to 
the bacteria’s specificity for iron.[23] Attempts have been 
made to address these issues by developing biomimetic 
approaches to produce artificial magnetosomes that 
can be more readily scaled up and adapted to achieve 
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Figure 1. Methodology of the synthesis. Schematic diagram showing experimental setup for the electrohydrodynamic production of arti-
ficial magnetosomes: (1) encapsulation of NaOH within DSPC liposomes via the EHDA jetting system, (2) showing the composition of the 
EHDA formed vesicles, (3) before being introduced to mixed valence iron solution and consequently electroporated at 750 V, and (4) to yield 
a magnetic nanoparticle within the vesicle core (artificial magnetosome).
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particular particle characteristics but currently these are 
subject to the same challenges as conventional inorganic 
protocols.[24–26] Our aim in this study was to develop a 
synthetic process that mimics magnetosome formation 
(Figure 1) and hence enables control over MNP forma-
tion, size, and lipid coating, while also offering much 
greater flexibility to adapt the system and increase yield.
2. Results
The process involves two steps: first, controlled high-
throughput production of liposomes was achieved using 
electrohydrodynamic atomization (EHDA), which offers a 
scalable means of generating tunable uniformed nanosized 
vesicles.[27,28] EHDA utilizes a high electrical potential dif-
ference to induce focusing and break up of a liquid jet into 
small droplets.[27–29] In this study, a syringe pump was used 
to generate a steady flow of lipid/base suspension through 
a stainless steel bi-port needle at 20 μL min−1 and an elec-
trical potential difference of 16.8–17.5 kV was applied to 
generate continuous stable jetting (see Sections S1 and S2, 
Supporting Information).
1,2-Distearoyl-sn-glycero-3-phosphocholine lipid (DSPC) 
was used which self-assembles into a high volume 
(73% yield, Section S3, Supporting Information) of 
near-monodisperse nanoliposomes when accelerated by 
jetting through the EHDA needle outlet; mimicking the 
invagination of the cytoplasmic membrane to form the 
empty magnetosome. The size of the resulting liposomes 
was found to be ≈22 nm ± 4.8 nm by dynamic light 
scattering (DLS) analysis and these results were supported 
by measurements from transmission electron microscopy 
(TEM) images (Figure 2).
DSPC can be difficult to work with in more traditional 
liposome synthesis methods, such as sonication or 
extrusion[30] owing to its high glass transition tempera-
ture (Tg). For DSPC the lipid solution must be kept above 
55 °C for it to remain amorphous, as below this critical 
temperature the lipid will be in the gel phase and can 
easily precipitate out of solution. This was evident during 
control tests of synthesis by tip sonication (Figure S4, 
Supporting Information). TEM analysis of liposomes 
prepared by both methods shows distinct differences. 
Those prepared by EHDA show clear vesicles with a near 
monodisperse distribution (Figure 2), which is in stark 
contrast to the sonicated control sample in which vesicles 
appeared to have been severely damaged by the prepara-
tion method (Figure S4a, Supporting Information). This 
can be attributed to the Tg of DSPC and different working 
temperatures of each method. It is possible that the 
negative effects of Tg are not observed in the EHDA pre-
pared sample due to the application of the high voltage 
during the continuous flow and rapid formation process, 
ensuring that the DSPC remains in the amorphous phase 
throughout. The application of the high voltage is not 
only responsible for the rapid formation of nanovesicles 
but also appeared to assist in the formation of a vesicular 
structure, hugely increasing their stability, compared 
with liposomes formed by tip sonication. EHDA formed 
liposomes remained stable for the studied period of 120 d 
(Figure 2).
Liposomes were then used as nanoreactors for 
magnetite mineralization. Magnetite is only able to 
precipitate within vesicles if iron ions (Fe2+, Fe3+) in 
solution surrounding the vesicle are transported into 
the interior to achieve an optimum concentration to 
induce nucleation.[31] Electroporation is widely used in 
molecular biology for the introduction of DNA or nucleic 
acids into cells.[32] The authors recently demonstrated 
that electroporation can also be utilized to open pores 
in the membrane for the in situ precipitation of MNPs 
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Figure 2. Size distribution of vesicles. a) The size distribution of 
non-electroporated liposomes obtained by DLS. b) TEM images of 
the NaOH encapsulated vesicles formed at optimized conditions 
(200 μm diameter, 96 mm needle length, 20 μL min−1 flow rate, 
16.8–17.5 kV voltage).
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in polymersome membranes,[33] and a similar approach 
was adopted in this study to permeabilize the DSPC 
liposomes. Application of a localized high electric field 
induces the reversible poration of the lipid membrane, 
enabling the transportation of iron ions across the mem-
brane into the liposome core, mimicking the role of the 
transmembrane ion-transport proteins found in the 
MTB magnetosome.
The electroporation conditions were optimized 
(voltage = 750 V, pulse duration = 100 μs, and number 
of pulses = 9) for the EHDA synthesized liposomes to 
maximize iron ions transport across the membrane. The 
pH gradient established across the membrane initiates 
the transport of iron ions (Fe2+, Fe3+) through the pores 
opened by electroporation.[34] Inside the liposomes, the 
iron ions react with NaOH (0.1 m) to form magnetite.[35,36] 
Figure 3 shows that electroporation of EHDA synthe-
sized DSPC liposomes results in the crystallization of a 
single magnetite nanoparticle within the liposome core, 
forming a near monodisperse population of artificial 
magnetosome 58 nm ± 8 nm (Figure 3). It is of note that 
these artificial magnetosomes are of comparable size and 
structure to natural magnetosomes, with the uniformed 
MNP filling the vesicle core. The mean size of the mag-
netosomes is increased compared to that of the pre-
cursor vesicles (22 nm), which may be due to agglom-
eration of vesicles during electroporation. Given that the 
EHDA method enables the initial vesicle size to be very 
tightly controlled by varying the processing parameters, 
it offers excellent opportunities for tuning magnetosome 
size to suit a given application.
Raman spectroscopy was used to confirm both the 
material composition of the magnetite nanoparticle 
formation and the presence of the lipid bilayer observed 
in TEM (Figure 4). Significant peaks were observed at 
662, 533–553, and 230 cm−1 indicating magnetite.[37] 
The peaks seen at 750 and 1100 cm−1 correspond to the 
presence of a phosphatidylcholine bilayer. However, 
Raman spectroscopy provides no spatial information, 
so fluorescence assays were employed to determine if 
the MNP is surrounded with lipid as suggested by TEM 




gies) discrete fluorescent vesicles were 
observed only in the magnetically 
separated and washed artificial mag-
netosome sample. Furthermore when 
placed in a magnetic field, movement 
of the discrete fluorescent vesicles 
was observed (Figure S5, Supporting 
Information). This was not the case 
for suspensions of uncoated MNP or 
pre-electroporated liposomes used as 
a control.
To confirm the presence of mag-
netic material, magnetic hysteresis and 
field-cooled/zero-field-cooled magnetic 
susceptibility measurements as a func-
tion of temperature were performed 
(Figure 5). The data clearly show the 
presence of magnetic material and a 
magnetic structural phase transition at 
118 K, known as the Verwey transition 
(Figure 5).[38] In magnetite the cubic 
magnetocrystalline axis switches from 
the body diagonal to the cube edge 
resulting in a magnitude loss of mag-
netic remnants through the Verwey 
transition, providing a simple magnetic 
fingerprint for magnetite. This indicates 
that single-domain magnetite crystals 
were indeed crystallized within the 
EHDA synthesized nanoliposomes.
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Figure 3. The effect of electroporation on nanovesicles. Unstained nanoliposomes sub-
jected to optimized (100 μs pulse duration, 9 pulses, 750 V) electroporation conditions 
show MNP crystallized in their interior. a) Left: Ambient temperature (298 K); right: 
selected area electron diffraction pattern of artificial magnetosome at room tempera-
ture (inset: corresponding artificial magnetosome TEM image). b) Cryogenic (77 K) TEM 
images.
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In this study a flow rate of 20 μL min−1 was used for 
generating the liposomes, yielding 440 mg of NaOH filled 
DSPC vesicles per 0.6 mL in 30 min. Assuming maximum 
conversion to magnetoliposomes on electroporation this 
equates to a theoretical artificial magnetosome yield 
of 3.7 kg L−1 d−1 (Section S3, Supporting Information) 
which represents a significant increase on the yields 
currently achievable for natural magnetosomes from 
MTB of 0.168 g L−1 d−1.[39] Furthermore, the technology 
already exists to engineer a scaled-up system with mul-
tiple processing channels in parallel with increased flow 
rates for higher volume throughput to realize orders of 
magnitude greater yields in shorter harvesting times.[40] 
The flexibility of the EDHA system for producing a 
range of artificial magnetosomes can also be readily 
demonstrated. For example, a proof-of-concept study is 
reported (Figure S6, Supporting Infor-
mation) using a different lipid (DOPC) 
to form magnetoliposomes. The aim of 
this study was to demonstrate the fea-
sibility of the method for forming mag-
netosomes, but we have also shown in 
previous work that particle size can be 
readily tuned by varying the combina-
tion of flow rate, electrical potential 
difference, and liquid properties (den-
sity, viscosity, and surface tension) 
used in EHDA processing.[27,28]
As highlighted in the Introduction, 
magnetosomes are very attractive 
nanomagnetic materials for nano-
technological applications due to their 
excellent size and shape definition. 
Potential applications range from infor-
mation storage, e.g., high-density multi-
dimensional recording, high-frequency 
electronics and spintronics, to targeted 
medical diagnostics and therapies, 
e.g., contrast agents for MRI imaging, 
site-specific chemotherapy, and hyper-
thermic cancer treatments. They are 
inherently biocompatible, stable, and 
easily dispersed due to their intrinsic 
lipid coating which, as above, can also 
be readily functionalized, e.g., by inclu-
sion of functional proteins to which 
antibodies can be conjugated. Once 
again the flexibility of EHDA in this 
respect is a considerable advantage as 
different types of coating material can 
be readily substituted to facilitate the 
required surface functionalization.
3. Conclusions
In conclusion, a simple high-throughput method has 
been demonstrated for producing single-domain mag-
netite nanoparticles in situ within liposomes, mim-
icking the production of magnetosomes within MTB. 
This has a number of important advantages. First, it 
provides a simplified abiotic model of the biomineraliza-
tion process. This model system could be used to probe 
the biomineralization process itself by sequentially 
inserting biomineralization proteins to better under-
stand their function. Second and crucially, the system 
enables the development of a scalable route for creating 
monodisperse populations of lipid-encapsulated single-
domain MNPs. The system is highly versatile, offering 
the potential to produce artificial magnetosomes with 
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Figure 4. The characterization of the iron oxide within the nanovesicles. a) Raman spec-
trum of artificial magnetosomes shows DSPC lipid encapsulating magnetite. Spectrum 
shows the presence of peaks representative of magnetite (at 230, 535, and 665 cm−1) and 
a phosphatidylcholine lipid bilayer (peaks highlighted at cm−1 and above). b) Lipophilic 
fluorescent dye incorporation (Bodipy), showing the presence of magnetically respon-
sive (Figure S5, Supporting Information) liposomes.
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a range of properties and sizes that cannot be achieved 
with natural magnetosomes.
4. Experimental Section
Materials: All reagents were purchased from Sigma Aldrich. 
DSPC was dissolved in ethanol (10 × 10−3 m). 0.1 m solutions of 
NaOH, FeCl2.4H2O, and FeCl3.6H2O were prepared in milli-Q H2O 
degassed with N2 to prevent oxidation. Fe3+ and Fe2+ iron solution 
were used in ratio of 2:1, respectively.
EHDA Synthesis of Liposomes: Liposomes were prepared by 
means of a single bi-port needle (200 μm internal diameter and 
96 mm length). This was connected via silicone tubing to syringes 
containing DSPC (10 × 10−3 m) solution and sodium hydroxide 
(0.1 m) solution mounted on syringe pumps drivers (Harvard 
Apparatus Ltd.). Solutions were pumped through the needle, 
which was connected to a high-voltage power supply at 0–30 kV 
(Glassman High Voltage, Tadley, UK), at a rate of 5–50 μL min−1. 
Liposome solution was collected in a petri dish 100–120 mm 
below the needle and loaded on a metallic jack attached to a nega -
tive electrode, containing degassed H2O. The applied voltages 
and flow rates were optimized to obtain steady multi-jetting 
and uniform liposomes (Sections S1 and S2, Supporting 
Information).
Control Liposome Analysis: Vesicle size and distribution were 
determined by DLS (ZetasizerNano ZS, Malvern Instruments, UK) 
and TEM (Philips CM 12 (80 kV) stained with 1% uranyl acetate 
for 10 s). Nanovesicles were analyzed by TEM at regular intervals 
over 0–120 d to assess stability.
Electroporation of Liposomes: Electroporation (ECM 2001 
Electro Cell Manipulator, Harvard Apparatus, USA) was per-
formed on pre-formed liposomes (0.5 mL) and iron oxide 
(Fe3+:Fe2+ 2:1) solution (0.5 mL) in an electroporation cuvette 
(BTX, electrode distance 2 mm). Parameters including pulse dura-
tion (0–100 μs), voltage (100–1500 V), and number of pulses (1–9) 
were optimized for iron oxide precipitation at 100 μs, 750 V, and 
9 pulses.
Electron Microscopy Imaging: The electroporated samples 
(5 μL) were prepared at ambient temperature (25 °C) without 
staining on 400 mesh copper-coated carbon grids (Agar Scien-
tific) before analysis by TEM (FEI Tecnai G2 Spirit) to determine 
the incorporation of iron into the liposomes. Selected area elec-
tron diffraction (SAED) images were collected from a specific 
artificial magnetosome using the microscope in diffraction 
mode. Images were collected at 120 × 10−3 m. Cryogenic-EM was 
used to further investigate the structure of the artificial magne-
tosomes. 2 μL of sample was added to a carbon film 300 mesh 
grids (Agar Scientific) and blotted for 6 s (at 100% humidity) and 
then plunged into liquid ethane using a Vitrobot Mark IV. Sam-
ples were visualized on an FEI Tecnai F20 microscope fitted with 
a Gatan 4K × 4K CCD camera.
Liposome Bilayer Detection: Presence of a lipid bilayer 
was confirmed using lipophilic dye BODIPY FL C5-ceramide 
(N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-
3-pentanoyl)sphingosine) added to an artificial magnetosome 
suspension (50 μL) in a 1% v/v ratio and stirred for 12 h to ensure 
bilayer incorporation. This was compared to a control sample of 
uncoated magnetic nanoparticles to which Bodipy was added 
in the same ratio. Both samples were analyzed by fluorescence 
microscopy (Leica DMI4000) to determine dye uptake.
Magnetic Analysis: To determine magnetic properties, sam-
ples were prepared by centrifugation (8000 rpm for 10 min). The 
supernatant was discarded and the sample was washed three 
times (10 mL of double distilled water bubbled with nitrogen 
gas). Vesicles were dried on a petri dish at the ambient tem-
perature. Magnetization data were obtained via cryogenic 
vibrating sample magnetometer or a super quantum conducting 
interference device magnetometer at different temperatures 
(ambient to 300 °C) and in sweeping fields up to 2.5 T, respec-
tively. Raman spectra were obtained with a confocal Raman 
spectrometer (Jobin Yvon LABRAM) equipped with an Nd-YAG 
laser (100 mW, 532.2 nm) and diffraction gratings of 1800 
grooves mm−1. Detection was performed using a Peltier-cooled, 
slow-scan, CCD matrix detector.
Supporting Information
Supporting Information is available from the Wiley Online 
Library or from the author.
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Figure 5. Magnetic properties of the artificial magnetosomes. 
Magnetization measurements at 300 K. a) Magnetization versus 
field hysteresis plot shows the soft magnetic material character-
istic of magnetite. b) ZFC and FC magnetisation versus tempera-
ture plot at 100 Oe. Inset shows remnance. The Verwey transition 
has been shown by —- and the temperature at which it occurs 
has been highlighted (118 K).
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